Long-term Debt and Lease Obligation of Vivos Therapeutics, Inc. from 30 Jun 2023 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of long-term debt and lease obligation, classified as noncurrent.
Summary
Vivos Therapeutics, Inc. quarterly Long-term Debt and Lease Obligation in USD history and change rate from 30 Jun 2023 to 31 Dec 2024.
  • Vivos Therapeutics, Inc. Long-term Debt and Lease Obligation for the quarter ending 31 Dec 2024 was $1,200,000, unchanged year-over-year.
Source SEC data
View on sec.gov
Long-term Debt and Lease Obligation, Quarterly (USD)
Long-term Debt and Lease Obligation, YoY Quarterly Change (%)

Vivos Therapeutics, Inc. Quarterly Long-term Debt and Lease Obligation (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $1,200,000 $0 0% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 $1,200,000 $0 0% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $1,200,000 $0 0% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q4 2023 $1,200,000 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $1,200,000 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $1,200,000 30 Jun 2023 10-Q 16 Aug 2023 2023 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.